The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2024

Filed:

Nov. 07, 2017
Applicant:

Macquarie University, North Ryde, AU;

Inventors:

Stephanie Rayner, Beecroft, AU;

Albert Lee, Silverwater, AU;

Roger Chung, Rhodes, AU;

Ian Blair, Collaroy Plateau, AU;

Assignee:

MACQUARIE UNIVERSITY, North Ryde, AU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); A61K 48/00 (2006.01); A61P 25/28 (2006.01); C07K 14/47 (2006.01); C12N 5/00 (2006.01); C12N 15/63 (2006.01); C12N 15/86 (2006.01); C12N 15/861 (2006.01); C12Q 1/6883 (2018.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0058 (2013.01); A61K 48/00 (2013.01); A61P 25/28 (2018.01); C07K 14/4738 (2013.01); C12N 15/86 (2013.01); C12N 15/861 (2013.01); C12Q 1/6883 (2013.01); G01N 33/5023 (2013.01); G01N 33/5058 (2013.01); C12N 2750/14141 (2013.01); C12N 2750/14143 (2013.01); C12Q 2600/158 (2013.01); G01N 2500/10 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01);
Abstract

Disclosed are compositions and methods for inhibiting abnormal protein accumulation, promoting motor neuron survival, inhibiting motor neuron degeneration and treating neurodegenerative conditions through expression of a nucleic acid sequence encoding cyclin F in motor neurons with an abnormally low level or activity of cyclin F. Also disclosed are methods for identifying agents that promote survival of motor neurons, inhibit degeneration of motor neurons and/or inhibit abnormal protein accumulation in motor neurons, identifying agents that are useful for treating neurodegenerative conditions, diagnosing neurodegenerative conditions, predicting the progression of neurodegenerative conditions, and monitoring the effectiveness of a therapy in reducing the progression of a neurodegenerative condition.


Find Patent Forward Citations

Loading…